NewAmsterdam Pharma N.V. Statistics
NASDAQ: NAMSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
21.12-1.01 (-4.56%)
Market open · Delayed 15 min · as of Oct 8, 12:05 PM ET
NewAmsterdam Pharma N.V. by the numbers
NewAmsterdam Pharma N.V. has a market capitalization of $2.47 billion based on 116.90M shares outstanding. With trailing EPS of $-2.16, NewAmsterdam Pharma N.V. is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.3% below its 50-day average and 31.8% below its 200-day average.
Average daily trading volume is 1.35M shares, or about $28.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NAMS valuation vs. peer median
| Metric | NAMS | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.47B | $2.58B | -4% |
| Avg. volume | 1.35M | 1.13M | +19% |
Peer median across 8 companies: MRVI, LQDA, ZLAB, PGEN, MBX, SUPN, HCM, RCUS.
Valuation
- Market cap
- $2.47B
- Price / sales (latest FY)
- 109.72
- EPS (TTM)
- $-2.16
- Shares outstanding
- 116.90M
Price and trading
- Previous close
- 22.13
- Open
- 22.00
- Day range
- 21.09 – 22.00
- 52-week range
- 21.02 – 42.21
- 52-week change
- -31.29%
- Beta
- —
- Volume
- 404.35K
- Average volume
- 1.35M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 2.47B
- Forward Pe
- -13.77
- Eps
- -2.16
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 42.21
- Week52 Low
- 21.02
- Avg Volume
- 1.35M
- Shares Outstanding
- 116.90M
- Ma50
- 25.23
- Ma200
- 30.99
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -49.96%
- Pct From52w Low
- 0.48%